F2 Cerebral Embolic Protection System
Prevention of brain injury/stroke during Transcatheter Aortic Valve Replacement (TAVR)
Pre-clinicalActive
Key Facts
Indication
Prevention of brain injury/stroke during Transcatheter Aortic Valve Replacement (TAVR)
Phase
Pre-clinical
Status
Active
Company
About EnCompass Technologies
EnCompass Technologies is developing the F2 cerebral embolic protection (CEP) system, an investigational device designed to capture debris during TAVR procedures to prevent stroke and other brain injuries. The company's technology aims to offer superior filtration, full coverage of the brain's blood vessels, and enhanced ease of use compared to existing options. With an experienced leadership team from the cardiovascular device industry and FDA conditional IDE approval for a U.S. pilot study, EnCompass is positioned to address a significant unmet need in the growing structural heart market.
View full company profile